First Trust ETF Vi (FV) 22.54 $FV Zacks Investment Ideas

New Post Public Reply Private Reply Replies (0) Message Board

Jun 24, 2016 at 9:09 AM

First Trust ETF Vi (FV) 22.54 $FV

Zacks Investment Ideas feature highlights: Vanguard International Dividend Appreciation ETF and First Trust Focus 5 ETF
Zacks Equity Research - Zacks Investment Research - Mon May 09, 8:30AM CDT
Zacks Investment Ideas feature highlights: Vanguard International Dividend Appreciation ETF and First Trust Focus 5 ETF
VIG: 82.95 (+0.82), FV: 22.54 (+0.35)

Best New ETFs for Your Portfolio
Neena Mishra - Zacks Investment Research - Fri May 06, 12:35PM CDT
These two ETFs are among the most promising products launched this year.
VIGI: 56.26 (+1.16), FVC: 20.89 (+0.28), VIG: 82.95 (+0.82), FV: 22.54 (+0.35)

ETF Picks for a Retirement Portfolio
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 10:50AM CDT
A few ETF strategies to construct a balanced retirement portfolio.
WMW: 23.79 (+0.25), MOAT: 33.40 (+0.50), MUB: 112.90 (-0.27), SPHD: 38.18 (+0.50), MOTI: 27.85 (+0.20), ACWV: 75.00 (+0.71), FV: 22.54 (+0.35), PEY: 15.58 (+0.25), VCLT: 92.07 (-0.07), TLT: 132.23 (-1.53)

Smart Beta ETFs Not So Smart?
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 11:43AM CDT
Smart beta ETFs appear to be losing some momentum with some underperforming the broader U.S. market.
SPY: 210.81 (+2.71), ONEO: 61.02 (+0.03), FV: 22.54 (+0.35), RZG: 82.70 (+1.44)

Zacks Investment Ideas feature highlights: Bob Evans Farms, PowerShares DWA Consumer Staples Momentum ETF, Shoe Carnival and First Trust Dorsey Wright Dynamic Focus 5 ETF
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 8:30AM CDT
Zacks Investment Ideas feature highlights: Bob Evans Farms, PowerShares DWA Consumer Staples Momentum ETF, Shoe Carnival and First Trust Dorsey Wright Dynamic Focus 5 ETF
SCVL: 25.04 (+0.03), BOBE: 39.69 (+0.13), FV: 22.54 (+0.35), PSL: 57.61 (+0.55)

The Safest Stocks and ETFs for Momentum Investors Right Now
Eric Dutram - ZACKS - Mon Mar 28, 11:26AM CDT
If investors like the momentum approach, then these four picks in the ETF and stock world will be great choices in this rocky market.
FVC: 20.89 (+0.28), SCVL: 25.04 (+0.03), BOBE: 39.69 (+0.13), FV: 22.54 (+0.35), PSL: 57.61 (+0.55)

The Zacks Analyst Blog Highlights: PowerShares S&P 500 Low Volatility Fund, iShares Russell 2000 ETF, First Trust Dorsey Wright Focus 5 ETF, Vanguard Total World Stock ETF and PowerShares S&P 500 Downside Hedged Portfolio
Zacks Equity Research - Zacks Investment Research - Fri Jan 08, 8:30AM CST
The Zacks Analyst Blog Highlights: PowerShares S&P 500 Low Volatility Fund, iShares Russell 2000 ETF, First Trust Dorsey Wright Focus 5 ETF, Vanguard Total World Stock ETF and PowerShares S&P 500 Downside Hedged Portfolio
PHDG: 24.92 (+0.29), VT: 59.49 (+1.17), SPLV: 41.70 (+0.33), IWM: 116.82 (+2.19), FV: 22.54 (+0.35)

Market Stings? 6 Techniques for a Winning ETF Portfolio
Sweta Killa - Zacks Investment Research - Thu Jan 07, 8:29AM CST
Investors should focus on certain techniques or strategies while building a portfolio for this year amid market turmoil.
PHDG: 24.92 (+0.29), VTI: 107.98 (+1.47), VT: 59.49 (+1.17), FTLB: 19.32 (-0.44), SPLV: 41.70 (+0.33), QUAL: 66.21 (+0.83), SCHA: 54.79 (+1.00), XLK: 43.97 (+0.59), VQT: 139.60 (+1.37), IWM: 116.82 (+2.19), BND: 83.23 (-0.15), FV: 22.54 (+0.35)

The Zacks Analyst Blog Highlights: SPDR S&P 500, PowerShares S&P 500 High Beta Portfolio, First Trust Dorsey Wright Focus 5 ETF, Financial Select Sector SPDR Fund, First Trust Dow Jones Internet Index and Utilities Select Sector SPDR
Zacks Equity Research - Zacks Investment Research - Mon Dec 28, 8:30AM CST
The Zacks Analyst Blog Highlights: SPDR S&P 500, PowerShares S&P 500 High Beta Portfolio, First Trust Dorsey Wright Focus 5 ETF, Financial Select Sector SPDR Fund, First Trust Dow Jones Internet Index and Utilities Select Sector SPDR
SPY: 210.81 (+2.71), FBT: 91.44 (+2.04), SPHB: 30.86 (+0.81), FDN: 73.85 (+1.39), XLU: 50.33 (+0.14), XLF: 23.33 (+0.48), FV: 22.54 (+0.35), FXH: 59.56 (+0.82)

The Tree is Up with the Best ETFs
Sweta Killa - Zacks Investment Research - Thu Dec 24, 9:26AM CST
We have build a tree with the choicest of ETFs of the season that can bring in bountiful returns for the investor with the jingle of Santa's bells.
SPY: 210.81 (+2.71), FBT: 91.44 (+2.04), SPHB: 30.86 (+0.81), CHOC: 47.10 (+1.36), FDN: 73.85 (+1.39), XLU: 50.33 (+0.14), XLF: 23.33 (+0.48), FV: 22.54 (+0.35), FXH: 59.56 (+0.82)

3 High Momentum Stocks & ETFs for the Santa Rally
Zacks Equity Research - Zacks Investment Research - Wed Dec 23, 12:31PM CST
Though stocks remained muted this December, these high momentum stocks and ETFs could see solid trading in the Santa Rally.
MTUM: 75.54 (+0.68), BGS: 46.65 (+0.88), AEO: 15.36 (+0.45), ONEO: 61.02 (+0.03), CZR: 8.67 (+0.29), FV: 22.54 (+0.35)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...